Prognostic impact of HLA supertype mismatch in single-unit cord blood transplantation
- 18 January 2024
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (4) , 466-472
Abstract
The “human leukocyte antigen (HLA) supertype” is a functional classification of HLA alleles, which was defined by structural features and peptide specificities, and has been reportedly associated with the clinical outcomes of viral infections and autoimmune diseases. Although the disparity in each HLA locus was reported to have no clinical significance in single-unit cord blood transplantation (sCBT), the clinical significance of the HLA supertype in sCBT remains unknown. Therefore, we retrospectively analyzed clinical data of 1603 patients who received sCBT in eight institutes in Japan between 2000 and 2017. Each HLA allele was categorized into 19 supertypes, and the prognostic effect of disparities was then assessed. An HLA-B supertype mismatch was identified as a poor prognostic factor (PFS: hazard ratio [HR] = 1.23, p = 0.00044) and was associated with a higher cumulative incidence (CI) of relapse (HR = 1.24, p = 0.013). However, an HLA-B supertype mismatch was not associated with the CI of acute and chronic graft-versus-host-disease. The multivariate analysis for relapse and PFS showed the significance of an HLA-B supertype mismatch independent of allelic mismatches, and other previously reported prognostic factors. HLA-B supertype-matched grafts should be selected in sCBT.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapseFrontiers in Immunology, 2013
- A Comparative Analysis of Viral Peptides Presented by Contemporary Human and Chimpanzee MHC Class I MoleculesThe Journal of Immunology, 2011
- How I treat: the selection and acquisition of unrelated cord blood graftsBlood, 2011
- Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageHaematologica, 2010
- Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African AmericansJournal of Virology, 2010
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- Dendritic cells in the thymus contribute to T-regulatory cell inductionProceedings of the National Academy of Sciences, 2008
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Identification of Peptide Vaccine Candidates for Prostate Cancer Patients with HLA-A3 Supertype AllelesClinical Cancer Research, 2005